Indication

Ulcerative proctitis

Ulcerative proctitis is a localized phenotypic subtype of ulcerative colitis, a chronic inflammatory bowel disease affecting the lower gastrointestinal tract. Read more about Ulcerative proctitis

32 drugs 24 manufacturers

Advertisement

Drugs that treat it

Common Ulcerative proctitis therapies.

Showing 10–18 of 32 drugs

MESALAMINE

INFLAMMATORY BOWEL AGENTS·ULCERATIVE PROCTITIS·+2
WALLACE PHARMAC

MESALAMINE

INFLAMMATORY BOWEL AGENTS·ULCERATIVE PROCTITIS·+2
ANI PHARMACEUTI

MESALAMINE

ULCERATIVE PROCTITIS·+2
L Perrigo Company

MESALAMINE

INFLAMMATORY BOWEL AGENTS·ULCERATIVE PROCTITIS
Mylan Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with Ulcerative proctitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Ulcerative proctitis.

Ulcerative proctitis is a localized phenotypic subtype of ulcerative colitis, a chronic inflammatory bowel disease affecting the lower gastrointestinal tract.

The condition is confined strictly to the rectal mucosa, originating at the dentate line and extending proximally without exceeding approximately fifteen centimeters from the anal verge.

Pathophysiologically driven by immune-mediated epithelial barrier dysfunction and mucosal inflammation, it is characterized endoscopically by confluent mucosal erythema, friability, and ulceration.

Clinically, affected patients most commonly present with recurrent hematochezia, fecal urgency, tenesmus, and the passage of rectal mucus, while systemic manifestations remain infrequent.

Personalize your experience

Follow Ulcerative proctitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it